FAMRI Scientific Publications

Presented here is a compilation of 4,250 FAMRI-supported peer-reviewed publications (as of February 16, 2022). These publications stem from 570 grants awarded to more than 500 different investigators. The outcome of the discoveries is inspiring and sets the stage for prevention, early detection, treatment, and cures of tobacco-related diseases. The results in these publications have contributed to, and continue to contribute to, the overall betterment of public health. The charts below illustrate FAMRI scientific publications by topic and by keywords.

Flight Attendant Medical Research Institute Publications and Presentations: 2022-23

Publications and Presentations: 2023

Rosen L, Zucker D, Gravely S, Bitan M, Rule A, Myers V. Tobacco Smoke Exposure According to Location of Home Smoking in Israel: Findings from the Project Zero Exposure Study. Int J Environ Res Public Health. 2023;20:1-13.

Publications and Presentations: 2022

Begum R, Thota S, Abdulkadir A, Kaur G, Bagam P, Batra S. NADPH oxidase family
proteins: signaling dynamics to disease management. Cell Mol Immunol.

Bitan M, Steinberg DM, Wilson SR, Kalkbrenner AE, Lanphear B, Hovell MF, Gamliel VM, Rosen LJ. Association between objective measures and parent-reported measures of child tobacco smoke exposure: A secondary data analysis of four trials. Tob Induc Dis. 2022;20:62.

Diaz Del Valle F, Zakrajsek JK, Min SJ, Koff PB, Bell HW, Kincaid KA, Frank DN,
Ramakrishnan V, Ghosh M, Vandivier RW. Impact of Airline Secondhand Tobacco Smoke Exposure on Respiratory Health and Lung Function Decades After Exposure Cessation. Chest. 2022;S0012-3692(22):00416-00420.

Garcia-Arcos I, Park SS, Mai M, Alvarez-Buve R, Chow L, Cai H, Baumlin-Schmid N, Agudelo CW, Martinez J, Kim MD, Dabo AJ, Salathe M, Goldberg IJ, Foronjy RF. LRP1 loss in airway epithelium exacerbates smoke-induced oxidative damage and airway remodeling. J Lipid Res. 2022;63(4):100185.

Guo X, Ghosh AK, Keyes RF, Peterson F, Forman M, Meyers DJ, Arav-Boger R. The Synthesis and Anti-Cytomegalovirus Activity of Piperidine-4-Carboxamides. Viruses. 2022;14(2).

Mustra Rakic J, Zeng S, Rohdin-Bibby L, Van Blarigan EL, Liu X, Ma S, Kane JP,
Redberg RF, Turino GM, Oestreicher Stock E, Arjomandi M. Elastin degradation and lung function deterioration with remote secondhand tobacco smoke exposure in never-smokers. Chronic Obstr Pulm Dis. 2022;9(3):377-393.

Moshitch-Moshkovitz S, Dominissini D, Rechavi G. The epitranscriptome toolbox.
Cell. 2022;185(5):764-776.


Numata M, Voelker DR. Anti-inflammatory and anti-viral actions of anionic pulmonary surfactant phospholipids. Biochim Biophys Acta Mol Cell Biol Lipids. 2022;1867(6):159139.

Ronish BE, Couper DJ, Barjaktarevic IZ, Cooper CB, Kanner RE, Pirozzi CS, Kim V, Wells JM, Han MK, Woodruff PG, Ortega VE, Peters SP, Hoffman EA, Buhr RG, Dolezal BA, Tashkin DP, Liou TG, Bateman LA, Schroeder JD, Martinez FJ, Barr RG, Hansel NN, Comellas AP, Rennard SI, Arjomandi M, Paine Iii R. Forced Expiratory Flow at 25%-75% Links COPD Physiology to Emphysema and Disease Severity in the SPIROMICS Cohort. Chronic Obstr Pulm Dis. 2022.

Sauler M, McDonough JE, Adams TS, Kothapalli N, Barnthaler T, Werder RB, Schupp JC, Nouws J, Robertson MJ, Coarfa C, Yang T, Chioccioli M, Omote N, Cosme C, Jr., Poli S, Ayaub EA, Chu SG, Jensen KH, Gomez JL, Britto CJ, Raredon MSB, Niklason LE, Wilson AA, Timshel PN, Kaminski N, Rosas IO. Characterization of the COPD alveolar niche using single-cell RNA sequencing. Nat Commun. 2022;13(1):494.

Seedahmed MI, Mogilnicka I, Zeng S, Luo G, Whooley MA, McCulloch CE, Koth L,
Arjomandi M. Performance of a Computational Phenotyping Algorithm for Sarcoidosis Using Diagnostic Codes in Electronic Medical Records: A Pilot Study
from Two Veterans Affairs Medical Centers. JMIR Form Res. 2022.

Sheban D, Shani T, Maor R, Aguilera-Castrejon A, Mor N, Oldak B, Shmueli MD, Eisenberg-Lerner A, Bayerl J, Hebert J, Viukov S, Chen G, Kacen A, Krupalnik V, Chugaeva V, Tarazi S, Rodriguez-delaRosa A, Zerbib M, Ulman A, Masarwi S, Kupervaser M, Levin Y, Shema E, David Y, Novershtern N, Hanna JH, Merbl Y. SUMOylation of linker histone H1 drives chromatin condensation and restriction of embryonic cell fate identity. Mol Cell. 2022;82(1):106-122 e109.

Solanki HS, Raja R, Zhavoronkov A, Ozerov IV, Artemov AV, Advani J, Radhakrishnan A, Babu N, Puttamallesh VN, Syed N, Nanjappa V, Subbannayya T, Sahasrabuddhe NA, Patil AH, Prasad TSK, Gaykalova D, Chang X, Sathyendran R, Mathur PP, Rangarajan A, Sidransky D, Pandey A, Izumchenko E, Gowda H, Chatterjee A. Targeting focal adhesion kinase overcomes erlotinib resistance in smoke induced lung cancer by altering phosphorylation of epidermal growth factor receptor [correction]. Oncoscience. 2021;8:108-109.

Thota S, Begum R, Kaur G, Bagam P, Dorsey W, Batra S. Pentachlorophenol mediated regulation of DAMPs and inflammation: In vitro study. Toxicol In Vitro. 2022;83:105378.

Wakefield TD, Glantz SA. The tobacco industry’s tort reform campaign to avoid
liability in Louisiana. Addict Behav. 2022;125:107147.

Zeng S, Dunn M, Gold WM, Kizer JR, Arjomandi M. Remote exposure to secondhand tobacco smoke is associated with lower exercise capacity through effects on oxygen pulse, a proxy of cardiac stroke volume. BMJ Open Respir Res. 2022;9(1).

Zeng S, Arjomandi M, Luo G. Automatically Explaining Machine Learning Predictions on Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective
Cohort Study. JMIR Med Inform. 2022;10(2):e33043.

Zeng S, Arjomandi M, Tong Y, Liao ZC, Luo G. Developing a Machine Learning Model to Predict Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study. J Med Internet Res. 2022;24(1):e28953.

Book Chapters, etc., 2022

Cummings KM, Brown A, Philipson B. History of the evolution of tobacco products. In: Hecht S, Hatsukami D, eds. Tobacco and Cancer: The Science and the Story Singapore: World Scientific Publishing Company, 2022.

Liu, J. Invention disclosure: ” Three-dimentional surface for protein and small
molecule microarrays.” 2022.